Unreported Antipsychotic Use Increasing in Nursing Homes: The Impact of Quality-Measure Exclusions on the Percentage of Long-Stay Residents Who Got an Antipsychotic Medication Quality-Measure |
| |
| Authors: | Jonathan D. Winter John William Kerns Katherine M. Winter Alicia Richards Roy T. Sabo |
| |
| Affiliation: | 1. VCU-Shenandoah Family Practice Residency (JDW, JWK, KMW), Front Royal, VA;2. Department Biostatistics, Department of Family Medicine and Population Health (JDW, JWK, AR, RTS), Virginia Commonwealth University, Richmond, VA |
| |
| Abstract: | ObjectiveExcluded from reporting to CMS's Percentage of long-stay residents who got an antipsychotic medication quality-measure are antipsychotics prescribed to nursing home patients with schizophrenia, Tourette's, or Huntington's. Over the 4 years following its 2012 debut, the quality-measure calculated a 27% reduction in inappropriate antipsychotic use but also an 18.3% increase in exclusion claims. This study evaluated the impact of these exclusions on the measure's findings.MethodsClaims data for the years 2011–2016 retrospectively identified the prevalence of schizophrenia, Tourette's, and Huntington's in quarterly cohorts of Virginia long-stay residents prescribed antipsychotics. Annualized diagnoses in 2011 were compared with subsequent years using simple logistic regression.ResultsIn 2016, 29% of the antipsychotics prescribed in Virginia nursing homes were to residents with diagnoses of schizophrenia, Tourette's, and Huntington's, a significant 32% increase from 2011.ConclusionAlmost 30% of the antipsychotics employed in Virginia nursing homes are excluded from CMS's long-stay antipsychotic quality-measure. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
